Linc00963 up-regulation alleviates postmenopausal osteoporosis through suppression of miR-506-3p

  • 0The First Orthopedic Rehabilitation Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, 100144, China.

|

|

Summary

This summary is machine-generated.

Long non-coding RNA linc00963 plays a role in postmenopausal osteoporosis by regulating miR-506-3p. Overexpression of linc00963 demonstrates therapeutic potential for osteoporosis.

Area Of Science

  • Molecular Biology
  • Endocrinology
  • Bone Biology

Background

  • Postmenopausal osteoporosis is a significant health concern.
  • Understanding the molecular mechanisms is crucial for developing effective treatments.
  • Long non-coding RNAs (lncRNAs) are emerging as key regulators in various biological processes, including bone metabolism.

Purpose Of The Study

  • To investigate the regulatory role of linc00963 in postmenopausal osteoporosis.
  • To elucidate the molecular mechanisms underlying linc00963's effect on bone metabolism.
  • To evaluate linc00963 as a potential therapeutic target for postmenopausal osteoporosis.

Main Methods

  • MC3T3-E1 cells were used to assess the effect of linc00963 on cell proliferation and gene expression (Runx2, OCN, collagenia-1, OPG, RANKL, RANK).
  • Dual luciferase reporter assay confirmed the interaction between linc00963 and miR-506-3p.
  • A postmenopausal osteoporosis rat model was established via ovariectomy (OVX) to evaluate the in vivo effects of linc00963 overexpression on bone mineral density (BMD) and serum markers.

Main Results

  • Cell studies indicated that linc00963 alleviates postmenopausal osteoporosis by down-regulating miR-506-3p.
  • In OVX rats, linc00963 overexpression significantly improved BMD, serum calcium, phosphorus, osteoprotegerin (OPG), and reduced inflammatory markers compared to the OVX group.
  • Linc00963 overexpression also modulated key bone metabolism markers, including alkaline phosphatase (ALP) and bone gla protein (BGP).

Conclusions

  • Linc00963 is implicated in the pathogenesis of postmenopausal osteoporosis.
  • Linc00963 exerts its effects by up-regulating miR-506-3p and influencing the OPG/RANKL/RANK signaling pathway.
  • Linc00963 represents a promising therapeutic target for managing postmenopausal osteoporosis.

Related Concept Videos

MicroRNAs 01:22

2.9K

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Menopause 01:28

106

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...

Bone Remodeling 01:40

38.0K

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Hormonal Control of Bone Remodeling

Parathyroid hormone (PTH) maintains homeostatic control of blood calcium levels by regulating bone resorption. PTH is...

Bone Disorders 01:29

3.4K

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Internal Receptors 01:31

68.8K

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.

Similar to membrane-bound receptors, binding of a ligand to a receptor located in the cytoplasm or nucleus of a cell...